EP2010499A4 - Composition pharmaceutique d'oxcarbazepine à particules de 15 à 30 microns en moyenne - Google Patents

Composition pharmaceutique d'oxcarbazepine à particules de 15 à 30 microns en moyenne

Info

Publication number
EP2010499A4
EP2010499A4 EP07718769A EP07718769A EP2010499A4 EP 2010499 A4 EP2010499 A4 EP 2010499A4 EP 07718769 A EP07718769 A EP 07718769A EP 07718769 A EP07718769 A EP 07718769A EP 2010499 A4 EP2010499 A4 EP 2010499A4
Authority
EP
European Patent Office
Prior art keywords
oxcarbazepine
microns
particle size
pharmaceutical compositions
median particle
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP07718769A
Other languages
German (de)
English (en)
Other versions
EP2010499A1 (fr
Inventor
Brett Antony Mooney
Panagiotis Keramidas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alphapharm Pty Ltd
Original Assignee
Alphapharm Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2006902079A external-priority patent/AU2006902079A0/en
Application filed by Alphapharm Pty Ltd filed Critical Alphapharm Pty Ltd
Publication of EP2010499A1 publication Critical patent/EP2010499A1/fr
Publication of EP2010499A4 publication Critical patent/EP2010499A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/18—Dibenzazepines; Hydrogenated dibenzazepines
    • C07D223/22—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2893—Tablet coating processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP07718769A 2006-04-21 2007-04-20 Composition pharmaceutique d'oxcarbazepine à particules de 15 à 30 microns en moyenne Withdrawn EP2010499A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2006902079A AU2006902079A0 (en) 2006-04-21 Pharmaceutical compound and composition
PCT/AU2007/000522 WO2007121523A1 (fr) 2006-04-21 2007-04-20 Composition pharmaceutique d'oxcarbazépine À PARTICULES DE 15 À 30 microns EN moyenne

Publications (2)

Publication Number Publication Date
EP2010499A1 EP2010499A1 (fr) 2009-01-07
EP2010499A4 true EP2010499A4 (fr) 2012-07-18

Family

ID=38624464

Family Applications (1)

Application Number Title Priority Date Filing Date
EP07718769A Withdrawn EP2010499A4 (fr) 2006-04-21 2007-04-20 Composition pharmaceutique d'oxcarbazepine à particules de 15 à 30 microns en moyenne

Country Status (3)

Country Link
EP (1) EP2010499A4 (fr)
AU (1) AU2007242062A1 (fr)
WO (1) WO2007121523A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007089926A2 (fr) * 2006-01-31 2007-08-09 Teva Pharmaceutical Industries Ltd. Preparations pharmaceutiques de l'oxcarbazepine et procedes pour sa preparation
CA2906107C (fr) * 2013-03-15 2021-08-24 Aprecia Pharmaceuticals Company Forme posologique d'oxcarbazepine a dispersion rapide
WO2015063670A1 (fr) * 2013-10-30 2015-05-07 Wockhardt Limited Composition orale solide a liberation modifiee comprenant de l'oxcarbazepine ou un sel pharmaceutiquement acceptable de ce compose

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998035681A1 (fr) * 1997-02-14 1998-08-20 Novartis Ag Comprimes d'oxacarbazepine enrobes par pelliculage
WO2002094774A2 (fr) * 2001-05-18 2002-11-28 Ranbaxy Laboratories Limited Formes galeniques d'oxcarbazepine
WO2007029093A2 (fr) * 2005-09-05 2007-03-15 Ranbaxy Laboratories Limited Formes galeniques de l'oxcarbazepine
WO2007053904A1 (fr) * 2005-11-10 2007-05-18 Alphapharm Pty Ltd Processus de regulation de la dimension de particule
WO2008037044A1 (fr) * 2006-09-27 2008-04-03 Medley S.A. Indústria Farmacêutica Formulation orale contenant oxcarbazépine et son procédé de production

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090196919A1 (en) * 2004-10-25 2009-08-06 Ajay Singla Oxcarbazepine dosage forms
WO2007007182A2 (fr) * 2005-07-08 2007-01-18 Aurobindo Pharma Limited Formes galeniques solides d'agent antiepileptique

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998035681A1 (fr) * 1997-02-14 1998-08-20 Novartis Ag Comprimes d'oxacarbazepine enrobes par pelliculage
WO2002094774A2 (fr) * 2001-05-18 2002-11-28 Ranbaxy Laboratories Limited Formes galeniques d'oxcarbazepine
WO2007029093A2 (fr) * 2005-09-05 2007-03-15 Ranbaxy Laboratories Limited Formes galeniques de l'oxcarbazepine
WO2007053904A1 (fr) * 2005-11-10 2007-05-18 Alphapharm Pty Ltd Processus de regulation de la dimension de particule
WO2008037044A1 (fr) * 2006-09-27 2008-04-03 Medley S.A. Indústria Farmacêutica Formulation orale contenant oxcarbazépine et son procédé de production

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2007121523A1 *

Also Published As

Publication number Publication date
WO2007121523A1 (fr) 2007-11-01
EP2010499A1 (fr) 2009-01-07
AU2007242062A1 (en) 2007-11-01

Similar Documents

Publication Publication Date Title
IL247417A0 (en) Use of solid carrier particles to improve the ability to process pharmaceutical material
AU2014221210A1 (en) The use of solid carrier particles to improve the processability of a pharmaceutical agent
ZA200900028B (en) Improvements relating to pharmaceutical compositions
IL195237A0 (en) Conjugates of aziridinyl-epothilone analogs and pharmaceutical compositions comprising same
GB0710369D0 (en) Improvements relating to perfume particles
SI1984009T1 (sl) Farmacevtski sestavki z izboljĺ ano stabilnostjo
IL195541A0 (en) Pharmaceutical compositions of memantine
EP2056835A4 (fr) Compositions pharmaceutiques et leurs utilisations
IL194546A0 (en) Arylaminopyridine derivatives and pharmaceutical compositions containing them
IL216361A0 (en) Anti-cancer compound and pharmaceutical composition containing the same
EP2104554A4 (fr) Compositions de particules
EP2431038A4 (fr) Composition pharmaceutique comprenant de l'arbidol sous forme de nanoparticules de phospholipides
IL193358A0 (en) Fluvastatin sodium pharmaceutical compositions
EP2070919A4 (fr) Composé de spiroquinone et composition pharmaceutique
ZA201006766B (en) Pharmaceutical composition 271
PT2409698E (pt) Utilização de um ácido indazol-metoxialcanóico para a preparação de uma composição farmacêutica
EP2010499A4 (fr) Composition pharmaceutique d'oxcarbazepine à particules de 15 à 30 microns en moyenne
AP2010005265A0 (en) Pharmaceutical compositions containing bradykinin antagonists and hyaluronic acid and uses thereof
IL191922A0 (en) Pharmaceutical formulations of oxcarbazepine and methods for its preparation
EP2275112A4 (fr) Composition pharmacologique antitumorale à base de terpénoïdes 'abissiline' possédant une action inhibitrice d'angiogenèse
IL198835A0 (en) Pharmaceutical compositions of memantine
IL253975A0 (en) Ibuprofen sodium tablets and methods for preparing medical preparations containing ibuprofen sodium
WO2008141751A3 (fr) Compositions pharmaceutiques comprenant de l'oxcarbazépine
ZA201200946B (en) Cosmetic compositions with gold particles and alkyl acid monoethanolamides
HK1124264A (en) Conjugates of aziridinyl-epothilone analogs and pharmaceutical compositions comprising same

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20081008

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR MK RS

A4 Supplementary search report drawn up and despatched

Effective date: 20120615

RIC1 Information provided on ipc code assigned before grant

Ipc: C07D 223/22 20060101AFI20120611BHEP

Ipc: A61K 31/55 20060101ALI20120611BHEP

Ipc: A61P 25/08 20060101ALI20120611BHEP

Ipc: A61K 9/20 20060101ALI20120611BHEP

DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20130115